Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 II. Extrapancreatic lesions, differential diagnosis
详细信息 查看全文
- 作者：Shigeyuki Kawa (1)
Kazuichi Okazaki (2)
Terumi Kamisawa (3)
Keishi Kubo (4)
Hirotaka Ohara (5)
Osamu Hasebe (6)
Yasunari Fujinaga (7)
Atsushi Irisawa (8)
Kenji Notohara (9)
Tetsuhide Ito (10)
Kazuo Inui (11)
Hiroyuki Irie (12)
Takayoshi Nishino (13)
Isao Nishimori (14)
Shigeki Tanaka (15)
Toshimasa Nishiyama (16)
Koichi Suda (17)
Keiko Shiratori (18)
Masao Tanaka (19)
Tooru Shimosegawa (20) - 刊名：Journal of Gastroenterology
- 出版年：2014
- 出版时间：May 2014
- 年：2014
- 卷：49
- 期：5
- 页码：765-784
- 全文大小：
- 参考文献：1. Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52:683鈥?.
2. Saegusa H, Momose M, Kawa S, et al. Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas. 2003;27:20鈥?.
3. Taniguchi T, Ko M, Seko S, et al. Interstitial pneumonia associated with autoimmune pancreatitis. Gut. 2004;53:770 (author reply 770鈥?71).
4. Hirano K, Kawabe T, Komatsu Y, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J. 2006;36:58鈥?1.
5. Erkelens GW, Vleggaar FP, Lesterhuis W, et al. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet. 1999;354:43鈥?.
6. Nakazawa T, Ohara H, Yamada T, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology. 2001;48:625鈥?0.
7. Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403鈥?.
8. Takeda S, Haratake J, Kasai T, et al. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transpl. 2004;19:474鈥?.
9. Uchiyama-Tanaka Y, Mori Y, Kimura T, et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis. 2004;43:e18鈥?5.
10. van der Vliet HJ, Perenboom RM. Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann Intern Med. 2004;141:896鈥?.
11. Chan SK, Cheuk W, Chan KT, Chan JK. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol. 2009;33:1249鈥?2.
12. Ohara H, Nakazawa T, Sano H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas. 2005;31:232鈥?.
13. Sugimoto T, Tanaka Y, Morita Y, et al. Is tubulointerstitial nephritis and uveitis syndrome associated with IgG4-related systemic disease? Nephrology (Carlton). 2008;13:89.
14. Komatsu K, Hamano H, Ochi Y, et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci. 2005;50:1052鈥?.
15. Zen Y, Kasahara Y, Horita K, et al. Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: histologic similarity to sclerosing pancreatitis. Am J Surg Pathol. 2005;29:275鈥?.
16. Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2009;33:1886鈥?3.
17. Zen Y, Fujii T, Sato Y, et al. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol. 2007;20:884鈥?4.
18. Shinji A, Sano K, Hamano H, et al. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc. 2004;59:506鈥?1.
19. Unno H, Saegusa H, Fukushima M, Hamano H. Usefulness of endoscopic observation of the main duodenal papilla in the diagnosis of sclerosing pancreatitis. Gastrointest Endosc. 2002;56:880鈥?.
20. Umemura T, Zen Y, Hamano H, et al. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology. 2007;46:463鈥?1.
21. Umemura T, Zen Y, Hamano H, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol. 2011;46 Suppl 1:48鈥?5.
22. Kasashima S, Zen Y, Kawashima A, et al. Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol. 2008;32:197鈥?04.
23. Yoshimura Y, Takeda S, Ieki Y, et al. IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med. 2006;45:897鈥?01.
24. Watanabe T, Fujinaga Y, Kawakami S, et al. Infraorbital nerve swelling associated with autoimmune pancreatitis. Jpn J Radiol. 2011;29:194鈥?01.
25. Nakamura A, Funatomi H, Katagiri A, et al. A case of autoimmune pancreatitis complicated with immune thrombocytopenia during maintenance therapy with prednisolone. Dig Dis Sci. 2003;48:1968鈥?1.
26. Okazaki K, Uchida K, Matsushita M, Takaoka M. How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol. 2007;42 Suppl 18:32鈥?.
27. Hamano H, Arakura N, Muraki T, et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41:1197鈥?05.
28. Kawa S, Okazaki K, Kamisawa T, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol. 2010;45:1264鈥?1.
29. Takuma K, Kamisawa T, Anjiki H, et al. Metachronous extrapancreatic lesions in autoimmune pancreatitis. Intern Med. 2010;49:529鈥?3.
30. Kawa S, Hamano H, Kiyosawa K. Autoimmune pancreatitis and IgG4-related disease. In: Rose N, MacKay I, editors. The autoimmune diseases, 5th edn. St Louis: Academic Press; 2013. pp. 935鈥?49.
31. Fujinaga Y, Kadoya M, Kawa S, et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol. 2009;76:228鈥?8.
32. Ozaki Y, Oguchi K, Hamano H, et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol. 2008;43:144鈥?1.
33. Kamisawa T, Egawa N, Inokuma S, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas. 2003;27:235鈥?.
34. Yamamoto M, Ohara M, Suzuki C, et al. Elevated IgG4 concentrations in serum of patients with Mikulicz鈥檚 disease. Scand J Rheumatol. 2004;33:432鈥?.
35. Yamamoto M, Harada S, Ohara M, et al. Clinical and pathological differences between Mikulicz鈥檚 disease and Sjogren鈥檚 syndrome. Rheumatology (Oxford). 2005;44:227鈥?4.
36. Kamisawa T, Tu Y, Sasaki R, et al. The relationship of salivary gland function to elevated serum IgG4 in autoimmune pancreatitis. Intern Med. 2007;46:435鈥?.
37. Manoussakis M, Mouttsopoulos H. Sjoegren syndrome. 4th ed. St Louis: Academic Press; 2006.
38. Kubota K, Wada T, Kato S, et al. Highly active state of autoimmune pancreatitis with Mikulicz disease. Pancreas. 2010;39:e6鈥?0.
39. Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz鈥檚 disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol. 2010;37:1380鈥?.
40. Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology. 2009;251:260鈥?0.
41. Takato H, Yasui M, Ichikawa Y, et al. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med. 2008;47:291鈥?.
42. Hamed G, Tsushima K, Yasuo M, et al. Inflammatory lesions of the lung, submandibular gland, bile duct and prostate in a patient with IgG4-associated multifocal systemic fibrosclerosis. Respirology. 2007;12:455鈥?.
43. Miyake K, Moriyama M, Aizawa K, et al. Peripheral CD4+ T cells showing a Th2 phenotype in a patient with Mikulicz鈥檚 disease associated with lymphadenopathy and pleural effusion. Mod Rheumatol. 2008;18:86鈥?0.
44. Tsushima K, Tanabe T, Yamamoto H, et al. Pulmonary involvement of autoimmune pancreatitis. Eur J Clin Invest. 2009;39:714鈥?2.
45. Shrestha B, Sekiguchi H, Colby TV, et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol. 2009;33:1450鈥?2.
46. Matsui S, Hebisawa A, Sakai F, et al. Immunoglobulin G4-related lung disease: clinicoradiological and pathological features. Respirology. 2013;18:480鈥?.
47. Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005;36:710鈥?.
48. Ito M, Yasuo M, Yamamoto H, et al. Central airway stenosis in a patient with autoimmune pancreatitis. Eur Respir J. 2009;33:680鈥?.
49. Yamamoto H, Yasuo M, Ito M, et al. Clinical features of central airway involvement in autoimmune pancreatitis. Eur Respir J. 2011;38:1233鈥?.
50. Nakazawa T, Ohara H, Sano H, et al. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229.
51. Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30:20鈥?.
52. Nishino T, Oyama H, Hashimoto E, et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol. 2007;42:550鈥?.
53. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706鈥?5.
54. Nakazawa T, Ohara H, Sano H, Aoki S, Kobayashi S, Okamoto T, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937鈥?4.
55. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193鈥?03.
56. Aoki S, Nakazawa T, Ohara H, et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients鈥?sera. Histopathology. 2005;47:147鈥?8.
57. Uehara T, Hamano H, Kawa S, et al. Distinct clinicopathological entity 鈥榓utoimmune pancreatitis-associated sclerosing cholangitis鈥? Pathol Int. 2005;55:405鈥?1.
58. Hamano H, Umemura T, Uehara T, et al. IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol. 2007;102:691鈥?.
59. Hayashi K, Nakazawa T, Ohara H, et al. Autoimmune sclerosing cholangiopancreatitis with little pancreatic involvements by imaging findings. Hepatogastroenterology. 2007;54:2146鈥?1.
60. Tamada K, Kanai N, Wada S. Utility and limitations of intraductal ultrasonography in distinguishing longitudinal cancer extension along the bile duct from inflammatory wall thickening. Abdom Imaging. 2001;26:623鈥?1.
61. Kitajima Y, Ohara H, Nakazawa T. Usefulness of transpapillary bile duct brushing cytology and forceps biopsy for improved diagnosis in patients with biliary strictures. J Gastroenterol Hepatol. 2007;22:1615鈥?0.
62. Arikawa S, Uchida M, Kunou Y, et al. Comparison of sclerosing cholangitis with autoimmune pancreatitis and infiltrative extrahepatic cholangiocarcinoma: multidetector-row computed tomography findings. Jpn J Radiol. 2010;28:205鈥?3.
63. Naitoh I, Nakazawa T, Ohara H, et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol. 2009;44:1147鈥?5.
64. Nakazawa T, Ohara H, Ando T, et al. Clinical evaluation of primary sclerosing cholangitis, sclerosing cholangitis with autoimmune pancreatitis and immunoglobulin G4 related sclerosing cholangitis without autoimmune pancreatits. Gut. 2008;57 Suppl 2:A52.
65. Wang WL, Farris AB, Lauwers GY, Deshpande V. Autoimmune pancreatitis-related cholecystitis: a morphologically and immunologically distinctive form of lymphoplasmacytic sclerosing cholecystitis. Histopathology. 2009;54:829鈥?6.
66. Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012;19:536鈥?2.
67. Hirano K, Tada M, Isayama H, et al. Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointest Endosc. 2010;71:85鈥?0.
68. Hyodo N, Hyodo T. Ultrasonographic evaluation in patients with autoimmune-related pancreatitis. J Gastroenterol. 2003;38:1155鈥?1.
69. Hyodo T, Hyodo N, Yamanaka T. Contrast-enhanced intraductal ultrasonography for thickened bile duct wall. J Gastroenterol. 2001;36:557鈥?.
70. Tamada K, Tomiyama T, Oohashi A, et al. Bile duct wall thickness measured by intraductal US in patients who have not undergone previous biliary drainage. Gastrointest Endosc. 1999;48:199鈥?03.
71. Otsuka H, Morita N, Yamashita K, Nishitani H. FDG-PET/CT findings of autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis. Ann Nucl Med. 2007;21:593鈥?.
72. Zen Y, Onodera M, Inoue D, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. 2009;33:1833鈥?.
73. Kuwatani M, Kawakami H, Makiyama H, et al. Autoimmune pancreatitis with retroperitoneal fibrosis which responded to steroid therapy but was complicated with refractory renal dysfunction. Intern Med. 2007;46:1557鈥?4.
74. Kasashima S, Zen Y, Kawashima A, et al. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg. 2009;49:1264鈥?1 (discussion 1271).
75. Saeki T, Saito A, Yamazaki H, et al. Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin Exp Nephrol. 2007;11:168鈥?3.
76. Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78:1016鈥?3.
77. Saeki T, Imai N, Ito T, et al. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol. 2009;71:173鈥?.
78. Takahashi N, Kawashima A, Fletcher JG, Chari ST. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology. 2007;242:791鈥?01.
79. Cornell LD, Chicano SL, Deshpande V, et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol. 2007;31:1586鈥?7.
80. Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615鈥?6.
81. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561鈥?.
82. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2002;51:1鈥?.
83. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626鈥?1.
84. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. New Engl J Med. 2001;344:732鈥?.
85. Kawa S, Hamano H, Kiyosawa K. Pancreatitis. In: Rose N, MacKay I, editors. The autoimmune diseases, 4th edn. St Louis: Academic Press; 2006, pp. 779鈥?86.
86. Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J Gastroenterol. 2007;42 Suppl 18:9鈥?4.
87. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646鈥?3.
88. Choi EK, Kim MH, Lee TY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas. 2007;35:156鈥?1.
89. Shimosegawa T, Chari ST, Frulloni L, et al. International Consensus Diagnostic Criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352鈥?.
90. Irie H, Honda H, Baba S, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol. 1998;170:1323鈥?.
91. Takahashi N, Fletcher JG, Fidler JL, et al. Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol. 2008;190:280鈥?.
92. Kawamoto S, Siegelman SS, Hruban RH, Fishman EK. Lymphoplasmacytic sclerosing pancreatitis (autoimmune pancreatitis): evaluation with multidetector CT. Radiographics. 2008;28:157鈥?0.
93. Chang WI, Kim BJ, Lee JK, et al. The clinical and radiological characteristics of focal mass-forming autoimmune pancreatitis: comparison with chronic pancreatitis and pancreatic cancer. Pancreas. 2009;38:401鈥?.
94. Sugiyama Y, Fujinaga Y, Kadoya M, et al. Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer. Jpn J Radiol. 2012;30:296鈥?09.
95. Chandan VS, Iacobuzio-Donahue C, Abraham SC. Patchy distribution of pathologic abnormalities in autoimmune pancreatitis: implications for preoperative diagnosis. Am J Surg Pathol. 2008;32:1762鈥?.
96. Ichikawa T, Sou H, Araki T. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology. 2001;221:107鈥?6.
97. Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol. 2004;99:932鈥?.
98. Maruyama M, Arakura N, Ozaki Y, et al. Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course. J Gastroenterol. 2012;47:553鈥?0.
99. Maruyama M, Arakura N, Ozaki Y, et al. Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients. Int J Rheumatol. 2013;2013:8.
100. Wakabayashi T, Kawaura Y, Satomura Y, et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol. 2003;98:2679鈥?7.
101. Nishino T, Oyama H, Toki F, Shiratori K. Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings. J Gastroenterol. 2010;45:988鈥?6.
102. Kamisawa T, Tu Y, Egawa N, et al. Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis? Abdom Imaging. 2009;34:381鈥?.
103. Lee TY, Kim MH, do Park H, et al. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol. 2009;193:343鈥?.
104. Matsubayashi H, Furukawa H, Maeda A, et al. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Pancreatology. 2009;9:694鈥?.
105. Shigekawa M, Yamao K, Sawaki A, et al. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis? J Hepatobiliary Pancreat Surg. 2009;17:269鈥?4.
106. Farrell JJ, Garber J, Sahani D, Brugge WR. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc. 2004;60:927鈥?6.
107. Sahani DV, Kalva SP, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology. 2004;233:345鈥?2.
108. Kamisawa T, Egawa N, Nakajima H, et al. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol. 2003;98:2694鈥?.
109. Sahai A, Zimmerman M, Aabakken L, et al. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc. 1998;48:18鈥?5.
110. R枚sch T, Lorenz R, Braig C, Feuerbach S, Siewert J, Schusdziarra V, et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc. 1991;37:347鈥?2.
111. Hoki N, Mizuno N, Sawaki A, et al. Diagnosis of autoimmune pancreatitis using endoscopic ultrasonography. J Gastroenterol. 2009;44:154鈥?.
112. Deshpande V, Mino-Kenudson M, Brugge WR, et al. Endoscopic ultrasound guided fine needle aspiration biopsy of autoimmune pancreatitis: diagnostic criteria and pitfalls. Am J Surg Pathol. 2005;29:1464鈥?1.
113. Williams D, Sahai A, Aabakken L, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut. 1999;44:720鈥?.
114. Eloubeidi M, Chen V, Eltoum I. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol. 2003;98:2663鈥?.
115. Mizuno N, Bhatia V, Hosoda W, et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol. 2009;44:742鈥?0.
116. Bang SJ, Kim MH, do Kim H, et al. Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis? Pancreas. 2008;36:84鈥?.
117. Levy MJ, Reddy RP, Wiersema MJ, et al. EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc. 2005;61:467鈥?2.
118. Inoue H, Miyatani H, Sawada Y, Yoshida Y. A case of pancreas cancer with autoimmune pancreatitis. Pancreas. 2006;33:208鈥?.
119. Witkiewicz AK, Kennedy EP, Kennyon L, et al. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum Pathol. 2008;39:1548鈥?1.
120. Motosugi U, Ichikawa T, Yamaguchi H, et al. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int. 2009;59:744鈥?.
121. Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537鈥?5.
122. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20:23鈥?. - 作者单位：Shigeyuki Kawa (1)
Kazuichi Okazaki (2)
Terumi Kamisawa (3)
Keishi Kubo (4)
Hirotaka Ohara (5)
Osamu Hasebe (6)
Yasunari Fujinaga (7)
Atsushi Irisawa (8)
Kenji Notohara (9)
Tetsuhide Ito (10)
Kazuo Inui (11)
Hiroyuki Irie (12)
Takayoshi Nishino (13)
Isao Nishimori (14)
Shigeki Tanaka (15)
Toshimasa Nishiyama (16)
Koichi Suda (17)
Keiko Shiratori (18)
Masao Tanaka (19)
Tooru Shimosegawa (20)
1. Center for Health, Safety and Environmental Management, Shinshu University, Matsumoto, Japan
2. Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan
3. Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
4. Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan
5. Department of Community-Based Medical Education, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
6. Department of Gastroenterology, Nagano Municipal Hospital, Nagano, Japan
7. Department of Radiology, Shinshu University School of Medicine, Matsumoto, Japan
8. Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Aizuwakamatsu, Japan
9. Department of Anatomic Pathology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan
10. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
11. Department of Gastroenterology, Second Teaching Hospital, Fujita Health University, Nagoya, Japan
12. Department of Radiology, Faculty of Medicine, Saga University, Saga, Japan
13. Department of Gastroenterology, Yachiyo Medical Center, Tokyo Women鈥檚 Medical University, Yachiyo, Japan
14. Nishimori Clinic, Kochi, Japan
15. Department of Acupuncture and Moxibusion, Tokyo Ariake University of Medical and Health Sciences, Tokyo, Japan
16. Department of Public Health and Hygiene, Kansai Medical University, Osaka, Japan
17. Department of Pathology, Tokyo-West Tokushukai Hospital, Tokyo, Japan
18. Department of Gastroenterology, Tokyo Women鈥檚 Medical University, Tokyo, Japan
19. Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
20. Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan - ISSN：1435-5922
文摘